Work

Supplementary Figures 6 - 7 from Combination of Anti-HER3 Antibody MM-121/SAR256212 and Cetuximab Inhibits Tumor Growth in Preclinical Models of Head and Neck Squamous Cell Carcinoma

Year: 2023

Type: supplementary-materials

Abstract: PDF file - 520KB, Supplementary Figure 6. CM combination inhibits EGFR and HER3 signaling activation in vivo. Supplementary Figure 7. Inhibition of pHER3 and pAKT expression by CM combination.

DOI: 10.1158/1535-7163.22501323

Authors: Ning Jiang, Dongsheng Wang, Zhongliang Hu, Hyung Ju C. Shin, Guoqing Qian, Mohammad Aminur Rahman, Hongzheng Zhang, A.R.M. Ruhul Amin, Sreenivas Nannapaneni, Xiaojing Wang, Zhengjia Chen, Gabriela Garcia, Gavin MacBeath, Dong M. Shin, Fadlo R. Khuri, Jun Ma, Zhuo G. Chen, Nabil F. Saba

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362611669

Cites:

Cited by:

Related to: 10